Boyi Liao

639 total citations · 1 hit paper
13 papers, 504 citations indexed

About

Boyi Liao is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Boyi Liao has authored 13 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Boyi Liao's work include Extracellular vesicles in disease (3 papers), Cancer Mechanisms and Therapy (3 papers) and Circular RNAs in diseases (3 papers). Boyi Liao is often cited by papers focused on Extracellular vesicles in disease (3 papers), Cancer Mechanisms and Therapy (3 papers) and Circular RNAs in diseases (3 papers). Boyi Liao collaborates with scholars based in China and United States. Boyi Liao's co-authors include Jian Zhou, Jia Fan, Jie Hu, Zhi Dai, Ya Cao, Weifeng Liu, Zheng Wang, Kaiqian Zhou, Feiyu Chen and Weifeng Shen and has published in prestigious journals such as Advanced Functional Materials, Hepatology and International Journal of Cancer.

In The Last Decade

Boyi Liao

12 papers receiving 502 citations

Hit Papers

Orally Administrated Hydrogel Harnessing Intratumoral Mic... 2024 2026 2025 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boyi Liao China 11 325 286 93 81 67 13 504
Aichun Li China 6 539 1.7× 360 1.3× 45 0.5× 50 0.6× 29 0.4× 8 641
Irene Lo China 7 198 0.6× 142 0.5× 71 0.8× 100 1.2× 147 2.2× 9 467
Xi Ai China 10 163 0.5× 80 0.3× 59 0.6× 101 1.2× 90 1.3× 24 361
Anisha Madhav United States 10 241 0.7× 135 0.5× 40 0.4× 58 0.7× 187 2.8× 12 490
Xianhuan Yu China 12 157 0.5× 114 0.4× 129 1.4× 77 1.0× 121 1.8× 22 338
Feiling Feng China 15 334 1.0× 278 1.0× 211 2.3× 65 0.8× 178 2.7× 37 628
Megan Karwan United States 6 140 0.4× 77 0.3× 70 0.8× 68 0.8× 78 1.2× 8 481
Dinglan Zuo China 14 249 0.8× 193 0.7× 76 0.8× 187 2.3× 100 1.5× 25 534
Yunxing Shi China 10 178 0.5× 123 0.4× 40 0.4× 145 1.8× 68 1.0× 17 386
Keshuai Dong China 14 193 0.6× 133 0.5× 56 0.6× 102 1.3× 131 2.0× 26 418

Countries citing papers authored by Boyi Liao

Since Specialization
Citations

This map shows the geographic impact of Boyi Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyi Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyi Liao more than expected).

Fields of papers citing papers by Boyi Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyi Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyi Liao. The network helps show where Boyi Liao may publish in the future.

Co-authorship network of co-authors of Boyi Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Boyi Liao. A scholar is included among the top collaborators of Boyi Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyi Liao. Boyi Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Li, Lei, et al.. (2024). Orally Administrated Hydrogel Harnessing Intratumoral Microbiome and Microbiota-Related Immune Responses for Potentiated Colorectal Cancer Treatment. Research. 7. 364–364. 45 indexed citations breakdown →
3.
Lai, Chengteng, Boyi Liao, Peng Song, et al.. (2022). Synovial fibroblast-miR-214-3p-derived exosomes inhibit inflammation and degeneration of cartilage tissues of osteoarthritis rats. Molecular and Cellular Biochemistry. 478(3). 637–649. 32 indexed citations
4.
Gan, Wei, Liang Qiao, Cheng Ye, et al.. (2021). A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE. Frontiers in Oncology. 11. 742630–742630. 10 indexed citations
5.
6.
Dong, Zhitao, Boyi Liao, Weifeng Shen, Chengjun Sui, & Jiamei Yang. (2019). Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma. Digestive Diseases and Sciences. 65(2). 480–488. 18 indexed citations
7.
8.
Liu, Weifeng, Jie Hu, Kaiqian Zhou, et al.. (2017). Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma. OncoTargets and Therapy. Volume 10. 3843–3851. 126 indexed citations
9.
Liao, Boyi, Zheng Wang, Jie Hu, et al.. (2015). PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection. Tumor Biology. 37(3). 2987–2998. 28 indexed citations
10.
Wang, Zheng, et al.. (2015). Oxidized Regenerated Cellulose Reduces the Amount of Fluid Drainage after Liver Resection: A Randomized Prospective Clinical Trial.. PubMed. 62(140). 951–4. 4 indexed citations
11.
Jiang, Jiahao, Yanfeng Liu, Ai‐Wu Ke, et al.. (2014). Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing. Hepatology. 59(6). 2216–2227. 37 indexed citations
12.
Hu, Jie, Zheng Wang, Boyi Liao, et al.. (2014). Human miR‐1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients. International Journal of Cancer. 135(5). 1187–1194. 96 indexed citations
13.
Hu, Jie, Zheng Wang, Chang‐Jun Tan, et al.. (2013). Plasma MicroRNA, a Potential Biomarker for Acute Rejection After Liver Transplantation. Transplantation. 95(8). 991–999. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026